Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity

Condition:   Squamous Cell Carcinoma of the Oral Cavity
Interventions:   Drug: GL-0817;   Drug: Hiltonol;   Drug: Sargramostim;   Drug: cyclophosphamide;   Drug: Placebo
Sponsor:   Gliknik Inc.
Not yet recruiting - verified August 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/2bYqUYA
via IFTTT